Industry Developments

Drugmakers will be limited to maximum price rises of 4.6% in Brazil's private prescription market between March 31 2008 and March 31 2009, according to an announcement by medicine... 2008-03-19

Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according... 2008-03-19

Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according... 2008-03-19

Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according... 2008-03-19

Around four antibiotics are set for review by the US FDA in 2008, which suggests that some life is being seen in an area of research that has been overlooked in recent years, according... 2008-03-19

Brazil's COINFAR, a biotech joint venture between Aché, Biolab Sanus and União Química, has made available BRL3mn (US$1.8mn) to develop compounds derived from the country's biodiversity.... 2008-03-18

Brazil's COINFAR, a biotech joint venture between Aché, Biolab Sanus and União Química, has made available BRL3mn (US$1.8mn) to develop compounds derived from the country's biodiversity.... 2008-03-18

Brazil's COINFAR, a biotech joint venture between Aché, Biolab Sanus and União Química, has made available BRL3mn (US$1.8mn) to develop compounds derived from the country's biodiversity.... 2008-03-18

Brazil's COINFAR, a biotech joint venture between Aché, Biolab Sanus and União Química, has made available BRL3mn (US$1.8mn) to develop compounds derived from the country's biodiversity.... 2008-03-18

US-based drugmaker Bristol-Myers Squibb (BMS) is reported to be feeling out potential buyers for its baby formula business, Mead Johnson. The unit is valued at between US$7bn-US$9bn... 2008-03-17